Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of the American Chemical Society
|
October 24, 2007
Catalyzing the translocation of polypeptides through attractive interactions
Aaron J Wolfe, Mohammad M Mohammad, Stephen Cheley, et al.
Biochimica Et Biophysica Acta
|
December 19, 2012
Does the lipid environment impact the open-state conductance of an engineered β-barrel protein nanopore?
Noriko Tomita, Mohammad M Mohammad, David J Niedzwiecki, et al.
Nature Structural & Molecular Biology
|
October 24, 2007
Structural insight into OprD substrate specificity
Shyamasri Biswas, Mohammad M Mohammad, Dimki R Patel, et al.
The EMBO Journal
|
November 17, 2007
Tetrahymena ORC contains a ribosomal RNA fragment that participates in rDNA origin recognition
Mohammad M Mohammad, Taraka R Donti, J Sebastian Yakisich, et al.
Journal of the American Chemical Society
|
May 15, 2012
Engineering a rigid protein tunnel for biomolecular detection
Mohammad M Mohammad, Raghuvaran Iyer, Khalil R Howard, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
December 11, 2012
Determination of the quaternary structure of a bacterial ATP-binding cassette (ABC) transporter in living cells
Deo R Singh, Mohammad M Mohammad, Suparna Patowary, et al.
Analytical Chemistry
|
June 27, 2017
Interrogating Detergent Desolvation of Nanopore-Forming Proteins by Fluorescence Polarization Spectroscopy
Aaron J Wolfe, Yi-Ching Hsueh, Adam R Blanden, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F Mutation
Juliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
Therapeutic Advances in Medical Oncology
|
October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)
Bora Lim, Angela Marx, Megumi Kai, et al.
Frontiers in Oncology
|
May 14, 2025
Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer
Sara Corvigno, Jun Yao, Amma Asare, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of the American Chemical Society
|
October 24, 2007
Catalyzing the translocation of polypeptides through attractive interactions
Aaron J Wolfe, Mohammad M Mohammad, Stephen Cheley, et al.
Biochimica Et Biophysica Acta
|
December 19, 2012
Does the lipid environment impact the open-state conductance of an engineered β-barrel protein nanopore?
Noriko Tomita, Mohammad M Mohammad, David J Niedzwiecki, et al.
Nature Structural & Molecular Biology
|
October 24, 2007
Structural insight into OprD substrate specificity
Shyamasri Biswas, Mohammad M Mohammad, Dimki R Patel, et al.
The EMBO Journal
|
November 17, 2007
Tetrahymena ORC contains a ribosomal RNA fragment that participates in rDNA origin recognition
Mohammad M Mohammad, Taraka R Donti, J Sebastian Yakisich, et al.
Journal of the American Chemical Society
|
May 15, 2012
Engineering a rigid protein tunnel for biomolecular detection
Mohammad M Mohammad, Raghuvaran Iyer, Khalil R Howard, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
December 11, 2012
Determination of the quaternary structure of a bacterial ATP-binding cassette (ABC) transporter in living cells
Deo R Singh, Mohammad M Mohammad, Suparna Patowary, et al.
Analytical Chemistry
|
June 27, 2017
Interrogating Detergent Desolvation of Nanopore-Forming Proteins by Fluorescence Polarization Spectroscopy
Aaron J Wolfe, Yi-Ching Hsueh, Adam R Blanden, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F Mutation
Juliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
Therapeutic Advances in Medical Oncology
|
October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)
Bora Lim, Angela Marx, Megumi Kai, et al.
Frontiers in Oncology
|
May 14, 2025
Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer
Sara Corvigno, Jun Yao, Amma Asare, et al.
Page
of 3